144 related articles for article (PubMed ID: 35896449)
21. Effect of metformin combined with lifestyle modification versus lifestyle modification alone on proinflammatory-oxidative status in drug-naïve pre-diabetic and diabetic patients: A randomized controlled study.
Bulatova N; Kasabri V; Qotineh A; Al-Athami T; Yousef AM; AbuRuz S; Momani M; Zayed A
Diabetes Metab Syndr; 2018 May; 12(3):257-267. PubMed ID: 29221717
[TBL] [Abstract][Full Text] [Related]
22. Screening for Prediabetes and Type 2 Diabetes in Children and Adolescents: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Vander Schaaf EB; Riley S; Allison BA; Middleton JC; Baker C; Ali R; Voisin CE; LeBlanc ES
JAMA; 2022 Sep; 328(10):968-979. PubMed ID: 36098720
[TBL] [Abstract][Full Text] [Related]
23. Metformin in Prevention of Type 2 Diabetes.
Snehalatha C; Priscilla S; Nanditha A; Arun R; Satheesh K; Ramachandran A
J Assoc Physicians India; 2018 Mar; 66(3):60-3. PubMed ID: 30341871
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Patients with Prediabetes in a Primary Care Setting 2011-2018: an Observational Study.
Speaker SL; Rastogi R; Sussman TA; Hu B; Misra-Hebert AD; Rothberg MB
J Gen Intern Med; 2021 Apr; 36(4):923-929. PubMed ID: 33449282
[TBL] [Abstract][Full Text] [Related]
25. The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study.
Andreadis EA; Katsanou PM; Georgiopoulos DX; Tsourous GI; Yfanti GK; Gouveri ET; Diamantopoulos EJ
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):175-80. PubMed ID: 19053032
[TBL] [Abstract][Full Text] [Related]
26. The use of glycated haemoglobin (HbA1
Mustafa IO; Tanko Y; Yusuf R; Musa SA
Diabetes Metab Syndr; 2019; 13(5):2967-2972. PubMed ID: 31437811
[TBL] [Abstract][Full Text] [Related]
27. Patterns of Diabetes Screening and Prediabetes Treatment during Office Visits in the US.
Shealy KM; Wu J; Waites J; Taylor NA; Blair Sarbacker G
J Am Board Fam Med; 2019; 32(2):209-217. PubMed ID: 30850457
[TBL] [Abstract][Full Text] [Related]
28. Review of Metformin Use for Type 2 Diabetes Prevention.
Moin T; Schmittdiel JA; Flory JH; Yeh J; Karter AJ; Kruge LE; Schillinger D; Mangione CM; Herman WH; Walker EA
Am J Prev Med; 2018 Oct; 55(4):565-574. PubMed ID: 30126667
[TBL] [Abstract][Full Text] [Related]
29. Clinical Care Among Individuals with Prediabetes in Primary Care: a Retrospective Cohort Study.
Tseng E; Durkin N; Clark JM; Maruthur NM; Marsteller JA; Segal JB
J Gen Intern Med; 2022 Dec; 37(16):4112-4119. PubMed ID: 35237886
[TBL] [Abstract][Full Text] [Related]
30. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
[TBL] [Abstract][Full Text] [Related]
31. Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005-2014.
Liu C; Foti K; Grams ME; Shin JI; Selvin E
J Gen Intern Med; 2020 Jan; 35(1):95-101. PubMed ID: 31637644
[TBL] [Abstract][Full Text] [Related]
32. Effect of Metformin on Anthropometric Measurements and Hormonal and Biochemical Profile in Patients with Prediabetes.
Safiah M; Hyassat D; Khader Y; Farahid O; Batieha A; El-Khateeb M; Ajlouni K
J Diabetes Res; 2021; 2021():8275303. PubMed ID: 34950736
[TBL] [Abstract][Full Text] [Related]
33. Drug therapy in prediabetes.
Mukhopadhyay P; Chowdhury S
J Indian Med Assoc; 2005 Nov; 103(11):603-5, 608. PubMed ID: 16570765
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of prediabetes in patients with acute coronary syndrome: impact on in-hospital outcomes.
AbuShady MM; Mohamady Y; Enany B; Nammas W
Intern Med J; 2015 Feb; 45(2):183-8. PubMed ID: 25443454
[TBL] [Abstract][Full Text] [Related]
35. Treating prediabetes with metformin: systematic review and meta-analysis.
Lily M; Godwin M
Can Fam Physician; 2009 Apr; 55(4):363-9. PubMed ID: 19366942
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
[TBL] [Abstract][Full Text] [Related]
37. Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans.
Kim CH; Kim HK; Kim EH; Bae SJ; Choe J; Park JY
Diabetes Res Clin Pract; 2016 Aug; 118():105-11. PubMed ID: 27368062
[TBL] [Abstract][Full Text] [Related]
38. Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus.
Sullivan SD; Jablonski KA; Florez JC; Dabelea D; Franks PW; Dagogo-Jack S; Kim C; Knowler WC; Christophi CA; Ratner R;
Diabetes Care; 2014 Apr; 37(4):909-11. PubMed ID: 24271189
[TBL] [Abstract][Full Text] [Related]
39. Considering metformin as a second-line treatment for children and adolescents with prediabetes.
Hosey CM; Halpin K; Yan Y
J Pediatr Endocrinol Metab; 2022 Jun; 35(6):727-732. PubMed ID: 35503504
[TBL] [Abstract][Full Text] [Related]
40. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
RISE Consortium
Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
